Agenus Inc. [AGEN] fell -23.29% so far this year. What now?

Agenus Inc. [NASDAQ: AGEN] traded at a low on 12/07/22, posting a -3.52 loss after which it closed the day’ session at $2.47. The company report on November 17, 2022 that Agenus Data at CTOS 2022 Highlight Durable Clinical Responses of Botensilimab / Balstilimab Combination in Advanced Sarcoma.

Will You Miss Out On This Growth Stock Boom?

A new megatrend in the fintech market is well underway. Mobile payments are projected to boom into a massive $12 trillion market by 2028. According to Motley Fool this growth stock could "deliver huge returns." Not only in the immediate future but also over the next decade. Especially since the man behind this company is a serial entrepreneur who has been wildly successful over the years.

And this is just one of our 5 Best Growth Stocks To Own For 2023.


Overall response rate (ORR) of 46% and disease control rate (DCR) of 69% in heavily pre-treated patients who have received a median of 3 prior lines of therapy.

Patient responses include sarcoma subtypes that historically do not respond to immunotherapy, including responses in 3 of 4 patients with visceral angiosarcoma.

The results of the trading session contributed to over 4570855 shares changing hands. Over the past one week, the price volatility of Agenus Inc. stands at 8.98% while the volatility over the past one month is 9.18%.

The market cap for AGEN stock reached $621.75 million, with 286.85 million shares outstanding and 244.08 million shares in the current float. Compared to the average trading volume of 4.75M shares, AGEN reached a trading volume of 4570855 in the most recent trading day, which is why market watchdogs consider the stock to be active.

What do top market gurus say about Agenus Inc. [AGEN]?

Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for AGEN shares is $8.25 per share. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on AGEN stock is a recommendation set at 1.50. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy.

SMBC Nikko have made an estimate for Agenus Inc. shares, keeping their opinion on the stock as Outperform, with their previous recommendation back on September 28, 2022. While these analysts kept the previous recommendation, H.C. Wainwright raised their target price to Buy. The new note on the price target was released on December 16, 2021, representing the official price target for Agenus Inc. stock. Previously, the target price had yet another raise to $6, while B. Riley FBR analysts kept a Buy rating on AGEN stock.

The Average True Range (ATR) for Agenus Inc. is set at 0.22, with the Price to Sales ratio for AGEN stock in the period of the last 12 months amounting to 6.92.

How has AGEN stock performed recently?

Agenus Inc. [AGEN] fell into the red zone at the end of the last week, falling into a negative trend and dropping by -8.52. With this latest performance, AGEN shares gained by 3.35% in over the last four-week period, additionally plugging by 45.29% over the last 6 months – not to mention a drop of -23.53% in the past year of trading.

Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for AGEN stock in for the last two-week period is set at 43.14, with the RSI for the last a single of trading hit 38.54, and the three-weeks RSI is set at 45.73 for Agenus Inc. [AGEN]. The present Moving Average for the last 50 days of trading for this stock 2.60, while it was recorded at 2.69 for the last single week of trading, and 2.40 for the last 200 days.

Agenus Inc. [AGEN]: Deeper insight into the fundamentals

Agenus Inc.’s liquidity data is similarly interesting compelling, with a Quick Ratio of 1.50 and a Current Ratio set at 1.50.

Insider trade positions for Agenus Inc. [AGEN]

There are presently around $405 million, or 59.60% of AGEN stock, in the hands of institutional investors. The top three institutional holders of AGEN stocks are: DEEP TRACK CAPITAL, LP with ownership of 26,325,000, which is approximately 18.36% of the company’s market cap and around 9.64% of the total institutional ownership; VANGUARD GROUP INC, holding 22,851,170 shares of the stock with an approximate value of $56.44 million in AGEN stocks shares; and BLACKROCK INC., currently with $53.26 million in AGEN stock with ownership of nearly 2.425% of the company’s market capitalization.

90 institutional holders increased their position in Agenus Inc. [NASDAQ:AGEN] by around 30,689,875 shares. Additionally, 56 investors decreased positions by around 13,658,840 shares, while 32 investors held positions by with 119,741,888 shares. The mentioned changes placed institutional holdings at 164,090,603 shares, according to the latest SEC report filing. AGEN stock had 25 new institutional investments in for a total of 3,173,733 shares, while 11 institutional investors sold positions of 2,088,162 shares during the same period.


Please enter your comment!
Please enter your name here